Literature DB >> 23648674

Motor neuron target selectivity and survival after prolonged axotomy.

Grant A Robinson1, Roger D Madison.   

Abstract

PURPOSE: After a cut peripheral nerve is repaired, motor neurons usually regenerate across the lesion site, however they often enter an inappropriate Schwann cell tube and may be directed to an inappropriate target organ such as skin, resulting in continued loss of function. In fact, only about 10% of adults who receive a peripheral nerve repair display full functional recovery. The reasons for this are many and complex, however one aspect is whether the motor neuron has undergone a prolonged period of axotomy prior to nerve repair. Previous studies have suggested a deleterious effect of prolonged axotomy.
METHODS: We examined the influence of prolonged axotomy on target selectivity using a cross-reinnervation model of rat obturator motor neurons regrowing into the distal femoral nerve, with its normal bifurcating pathways to muscle and skin.
RESULTS: Surprisingly, we found that a prolonged period of axotomy resulted in an increase in motor neuron regeneration accuracy. In addition, we found that regeneration accuracy could be increased even further by a simple surgical manipulation of the distal terminal nerve pathway to skin.
CONCLUSIONS: These results suggest that under certain conditions prolonged axotomy may not be detrimental to the final accuracy of motor neuron regeneration and highlight that a simple manipulation of terminal nerve pathways may be one approach to increase such regeneration accuracy.

Entities:  

Mesh:

Year:  2013        PMID: 23648674      PMCID: PMC3779651          DOI: 10.3233/RNN-120301

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  31 in total

1.  Preferential motor reinnervation in the mouse: comparison of femoral nerve repair using a fibrin sealant or suture.

Authors:  Grant A Robinson; Roger D Madison
Journal:  Muscle Nerve       Date:  2003-08       Impact factor: 3.217

2.  Motor neurons can preferentially reinnervate cutaneous pathways.

Authors:  Grant A Robinson; Roger D Madison
Journal:  Exp Neurol       Date:  2004-12       Impact factor: 5.330

3.  Contributions of pathway and neuron to preferential motor reinnervation.

Authors:  T M Brushart; J Gerber; P Kessens; Y G Chen; R M Royall
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

4.  Preferential motor reinnervation: a sequential double-labeling study.

Authors:  T M Brushart
Journal:  Restor Neurol Neurosci       Date:  1990-01-01       Impact factor: 2.406

5.  A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor.

Authors:  J G Boyd; T Gordon
Journal:  Eur J Neurosci       Date:  2002-02       Impact factor: 3.386

6.  Motor axons preferentially reinnervate motor pathways.

Authors:  T M Brushart
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

7.  Acceleration of axonal outgrowth in rat sciatic nerve at one week after axotomy.

Authors:  J M Jacob; I G McQuarrie
Journal:  J Neurobiol       Date:  1993-03

Review 8.  The possible role of "sibling neurite bias" in the coordination of neurite extension, branching, and survival.

Authors:  N R Smalheiser; S M Crain
Journal:  J Neurobiol       Date:  1984-11

9.  Manipulations of the mouse femoral nerve influence the accuracy of pathway reinnervation by motor neurons.

Authors:  Grant A Robinson; Roger D Madison
Journal:  Exp Neurol       Date:  2005-03       Impact factor: 5.330

10.  Delayed nerve repair is associated with diminished neuroenhancement by FK506.

Authors:  Michael J Brenner; Ida K Fox; David H Kawamura; Vivian M Yu; James B Lowe; Daniel A Hunter; Susan E Mackinnon
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

View more
  1 in total

1.  Controlling the Release of Neurotrophin-3 and Chondroitinase ABC Enhances the Efficacy of Nerve Guidance Conduits.

Authors:  Anthony Donsante; Jiajia Xue; Kelly M Poth; Nathan S Hardcastle; Bruna Diniz; Deirdre M O'Connor; Younan Xia; Nicholas M Boulis
Journal:  Adv Healthc Mater       Date:  2020-06-16       Impact factor: 9.933

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.